"Supportive care" may hold less stigma than "palliative care"
the ONA take:
Hematologic specialists were less likely to refer patients early in the disease trajectory to palliative care and were conducive to referral with the service name supportive care instead of palliative care, a new study published online ahead of print in the journal The Oncologist has shown.
Because palliative care referrals are often delayed for patients with hematologic malignancies, researchers sought to examine the differences in attitudes and beliefs toward palliative care referral between hematologic and solid tumor specialists and how their perception was altered with the service name supportive care instead of palliative care.
For the study, researchers surveyed 120 hematologic and 120 solid tumor oncology specialists at University of Texas MD Anderson Cancer Center in Houston, Texas.
Results showed that hematologic specialists were less likely than solid tumor specialists to report that they would refer symptomatic patients with newly diagnosed cancer to palliative care.
Researchers also found that a significantly greater proportion of oncology specialists reported that they would refer a patient with newly diagnosed cancer to supportive care than palliative care, even though they both provide the same service.
“These findings suggest that rebranding might help to overcome the stigma associated with palliative care and improve patient access to palliative care services,” the authors conclude.
Hematologic specialists were less likely to refer patients early in the disease trajectory to palliative care.
Sign Up for Free e-newsletters
- Education May Better Equip Nurses to Hold End-of-Life Conversations in Advanced Cancer
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|